Esperion Therapeutics Inc (fra:0ET) Share Price

Company Profile

Business description
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Contact
3891 Ranchero Drive
Suite 150
Ann ArborMI48108
USA
T: +1 734 887-3903
E: [email protected]
https://www.esperion.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
304

Recommended

Higher sales and a new loan facility increase our conviction.

Shane Ponraj, CFA | 15 January 2026

We’ve raised our fair value estimate of Taiwan Semiconductor stock.

Phelix Lee | 15 January 2026

Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 15 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,221.20	37.00	0.40%
CAC 40	8,313.12	17.84	-0.21%
DAX 40	25,352.39	66.15	0.26%
Dow JONES (US)	49,442.44	292.81	0.60%
FTSE 100	10,238.94	54.59	0.54%
HKSE	26,853.90	69.72	-0.26%
NASDAQ	23,530.02	58.27	0.25%
Nikkei 225	53,969.74	140.76	-0.26%
NZX 50 Index	13,717.38	57.59	0.42%
S&P 500	6,944.47	17.87	0.26%
S&P/ASX 200	8,897.90	36.20	0.41%
SSE Composite Index	4,103.45	9.16	-0.22%